By upholding estern standards of ethics for drug trials, a company will not only meet its ethical obligations but will also ensure a higher standard of research. Clinical trials in emerging markets will still be cheaper than in estern markets, because the research staff will earn less, and because payouts to test subjects can be adjusted for living costs without violating ethical norms. Also, because standards provide structure, the quality of the research will be improved by applying estern standards in lieu of local standards.
Thus, the strongest ethical case lies for managing drug trials in emerging markets much as they would be managed in the est. The trials need to meet the specifications of the FDA anyway, and even with estern standards the cost of foreign drug trials will be lower. Additionally, when the drug company is free from the perception of ethical violation, not only will the results…...
mlaWorks Cited:
Rettue, P. (2012). Clinical trials in emerging economies- challenges and opportunities. Medical News Today. Retrieved November 10, 2012 from http://www.medicalnewstoday.com/articles/246778.php
Singh, K. (2012). Lack of compensation norms for clinical trials results in exploitation of poor patients. The Economic Times. Retrieved November 10, 2012 f rom http://articles.economictimes.indiatimes.com/2012-08-21/news/33303228_1_clinical-trials-drug-trials-trial-victim
Medication Adherence and Compliance
Uncontrolled variables in psychiatric clinical drug trials
According to Griswold, Murray & Corrado (2012), one troubling aspect of psychotropic drug clinical trials is the lack of controls for subjects' adherence to medication protocols. Psychiatric patients in particular have historically been noted to have relatively low levels of compliance. In general, "as drug dosages increase, treatment adherence decrease" because of intensification of symptoms, difficulty remembering dosages, and other issues (Griswold, Murray & Corrado 2012). Under-medicating or discontinuing medications is common in schizophrenic and bipolar patients, due to reasons such as "perceived or real decreases in disease progression or symptomatology, perceived helplessness, defense mechanisms such as denial, motivational apathy, and lack of family or financial support"(Griswold, Murray & Corrado 2012). For potentially addictive substances such as stimulants and opioids, over-medication is a greater risk.
The study specifically took the form of a literature review. The authors conducted a search using clinical…...
mlaReference
Griswold L., Murray J., & Corrado P. (2012). Medication adherence and compliance:
Uncontrolled variables in psychiatric clinical drug trials. Adv. Pharmacoepidem Drug Safety 1:107. doi:10.4172/2167-1052.1000107
Minimizing isk in a Study
One of the biggest challenges in conducting pharmaceutical research are the risks involved. This is because they can increase the potential legal liabilities and have a negative impact on everyone. To address them requires looking at: the circumstance for exclusion / inclusion / the maximum results, who approves the modifications and what can cause a study to end prior to its completion. Together, these different elements will illustrate how the process occurs and the different variables that are utilized throughout the process. (Konterman, 2010)
Under what circumstances would you modify inclusion and exclusion data to minimize risk and to maximize benefits of the research outcome? Who must approve modifications?
The circumstances that will shift modification of risk in Phase III trials are the side effects and the impacts they will have on participants. This is challenging, as these issues could have short or long-term consequences. In these kinds…...
mlaReferences
Inside Clinical Trials. (2015). FDA. Retrieved from: http://www.fda.gov /Drugs/ResourcesForYou/Consumers/ucm143531.htm
Konterman, K. (2010). Anti-Body Engineering. New York, NY: Springer.
14). Soon, Congress passed the Marijuana Tax Act, which was signed into law in 1937. Like the Harrison Act, the Marijuana Tax Act placed marijuana into the same category as the cocaine and opium drugs. It was now illegal to import marijuana into the United States (McWilliams, 1991). However, this law was ineffective in curbing marijuana use (Brecher, 1986, p. 14).
By the early 1940s narcotic addiction had significantly reduced in the United States (Harrison, Backenheimer and Inciardi, 1999). However, this was not the result of legislative initiatives. Instead, it was because World War II was cutting off the "supplies of opium from Asia and interrupt the trafficking routes from Europe" (Inciardi, 1992, p. 24).
Several other legislative efforts in the supply reduction department served to establish more severe penalties for violations of drug laws, and tighten controls and restrictions over legally manufactured narcotic drugs (Harrison, Backenheimer and Inciardi, 1999). The…...
mlaReferences
1999). Recreational Drug Information. History of Drug Use U.S. Retrieved from the Internet at www.a1b2c3.com/drugs/.
Brecher, E. (1986). Drug Laws and Drug Law Enforcement: A Review and Evaluation Based on 111 Years of Experience,' Drugs and Society 1:1.
Drucker, Ernest. (1999). Harm Reduction: A Public Health Strategy. Current Issues in Public Health, 1: pp. 64-70.
Drug Policy Alliance. (February 17, 2005). Harm Reduction: Options that Work. Retrieved from the Internet at http://www.drugpolicy.org/news/021705harm.cfm .
According to these authors, the fatal tragedy could easily have been avoided by taking more time for more focused and carefully planned clinical trials. According to this view, it was unethical to test Tysabri in the way it has been done, and furthermore irresponsible to enter it into the market before all side-effects were ascertained.
3. Interested parties: The interested parties in this case include Walter Smith, Anita's widower, as well as Cambridge biotechnology and Elan Corp. From Smith's point-of-view, the companies are at fault for causing harm to his wife, and potential harm to many others using the drug. His current assertions regarding the reentry of the drug into the market appear to be well thought out and mature, focusing on the future benefit of patients rather than on his own need for revenge.
From the point-of-view of the companies, the drug is developed to help those suffering from multiple…...
United Drug is a Dublin-based firm that describes itself as "a provider of outsourced commercialisation solutions to healthcare companies operating across three divisions." The three divisions are Healthcare Supply Chain; Sales, Marketing and Medical; and Packaging and Specialty. Supply Chain involves wholesaling, sales and distribution and sometimes manufacturing. The Sales, Marketing and Medical division includes as functions contrast sales outsourcing, sales force consulting, and healthcare communications. The Packaging and Specialty division focuses on a number of packaging functions, Cold Chain delivery, nursing services to the home and vaccines. According to the 2011 Annual Report, the company's vision is "to be a true innovator in the provision of value enhancing and integrated product/service solutions in key international healthcare markets, enabling better market outcomes for producers, providers, payers and patients."
The company's mission is "to be a leader in all key international markets in the provision of exceptional integrated and market specific outsourcing…...
mlaWorks Cited:
Kellett, B. (2012). NHS cuts and staff reductions: Is it any wonder nurses are so unhappy? The Guardian. Retrieved May 2, 2012 from http://www.guardian.co.uk/commentisfree/2012/mar/22/nurses-unhappy-nhs-staff-budget-cuts
MindTools.com (2012). Porter's five forces. MindTools.com. Retrieved May 2, 2012 from http://www.mindtools.com/pages/article/newTMC_08.htm
ONS. (2012). Quarterly national accounts Q4 2011. Office for National Statistics. Retrieved May 2, 2012 from http://www.ons.gov.uk/ons/rel/naa2/quarterly-national-accounts/q4-2011/stb-quarterly-national-accounts-gdp-q4-2011.html
QuickMBA. (2010). Porter's generic strategies. QuickMBA. Retrieved May 2, 2012 fromhttp://www.quickmba.com/strategy/generic.shtml
Anti-Cancer Drug Anaerobin
a) EFFECTS ON KIDNEYS, HEART AND BRAIN
Cytotoxic metabolites are created when bio-reductive drugs go through a metabolic process because they contribute to curing cancer by lowering oxygen to areas where the cancer affects the body. The local auto regulation process of the body provides the oxygen to all parts of the body where it is needed. The arterioles supplying that tissue for oxygen dilate to supply more oxygen than usual. This happens also in the case of the tumor when it demands more oxygen; it is supplied by the body and anaerobin affects the auto regulation process in all areas as it reduces the blood flow to all organs, except the lungs. It can reduce the oxygen and supply of nutrients to the tumor by up to 99%. Therefore this bio-reductive drug can help in treatment of cancer in modern therapy.
Anti-cancer drugs reduce the cell growth of the…...
mlaLinda Bren, 2005. Cancer Drugs: weighing the Risks and Benefits. FDA Consumer, 41(1), pp.10+.
Nootropic. Available at: Http://en.wikipedia.org/wiki/Nootropic#Vitamins_and_supplements (Accessed at 2 December 2011)
Paual Ravasco, Isabel Monterio-Grillo, Pedro Marques Vidal & Maria Ermelinda Camilio, 2005. Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing Radiotherapy. Journal of Clinical Oncology, 23(7), pp. 1431-1438.
S. Food and Drug Administration, because they were in wide use before the 1938 Act (grandfathered in, as it were). (Dunn 1938)
The problem was that Act contained a definition for a "new drug" (one in need of prior approval to market), as any drug "the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling." FDCA § 201(p) (1). The manufacturers set out to establish then, that anything GRAS/GRAE therefore was not a new drug, and needed no FDA blessing.
Many medicines are ancient, and the active ingredients of many drugs on were first introduced before 1938. To make matters worse, between 1938 and 1962, the FDA considered drugs that were identical, related, or similar (IRS) to…...
The structure of yetta is similar to that of GLP-1 and performs the same functions. oth promote decreased appetite (Wilson).
Dr. Wysham was an observer at a study conducted on 20 Rockwood diabetic patients who were taking conventional diabetic medication for their uncontrolled blood sugar (Wilson 2005). She was not informed about their glucose levels for several months after the tests began. About two-thirds of the respondents were given different injectible doses of yetta to incorporate into their medication plan, while the rest were given placebos. All of them were instructed and trained to do the injections at certain times twice daily for a month. Then they were subjected to a physical exam. Dr. Wysham closely monitored their liver, kidney, blood counts, and other functions. She observed that the patients consistently lose weight while taking yetta. The average respondent-patient lost 15 pounds in the duration of the study, 5 lost…...
mlaBibliography
Business Editors (2005). Understand the impact of regulatory reform and raised drug
Safety awareness on off-label drug use. 2 pages. Business Wire: Gale Group
2007). Januvia approved in the European Union for the treatment of type-2 diabetes. 4 pages.
2007). Late breaking data released at ADA showed that the investigational use of Januvia and Metformin as initial combination therapy provided significant glucose lowering efficacy over 54 weeks in patients with type 2 diabetes. 8
IV. TESTING ON HUMANS
The only thing that is lacking at this point according to all reports is for testing on humans to be completed. The Time Asia articles states: "The last step for the ace-2 inhibitor, as for any drug, is human clinical trials. ecause the U.S. Food and Drug Administration requires such rigorous testing, this is by far the most expensive part of drug development. So for human trials in some cases, Millennium has formed partnerships with large pharmaceutical companies that have the necessary resources and will share in any eventual profits." (2001)
SUMMARY & CONCLUSION
According to the work entitled: "rave New Pharmacy" published in Time Asia (2001) "When the human genome was sequenced...scientists finally gained access to the full text of God's reference manual; the 3 billion biochemical 'letters' that spell out our tens of thousands of genes. These genes, strung out along the 46 chromosomes in virtually every…...
mlaBibliography
Drug Design in the Fast Lane: Speeding Drug Design (nd)
Elmer-Dewitt, Phillip (2001) The Future of Drugs. Time Asia 22 January 2001 Vol. 57, No. 3 Online available at http://www.time.com/time/asia/magazine/2001/0122/cover1.html .
Lemonick, Michael, D. (2001) Brave New Pharmacy - Time Asia 22 Jan 2001 Vol. 157. No. 3 Online available at http://www.time.com/time/asia/magazine/2001/0122/drug.impact.html
Michael Lauren who is struggling with drug problem. Michele Lauren is twenty-one-year-old girl, single and a resident of New York City. Michele lives with her parents and is addicted to marijuana. She was arrested on various circumstances, each time for the violation of Health & Safety Code 11357 (Samaha, 2007) that is the possession of large quantity of drugs and was locked up behind the bars on trials during the years 2002 to 2008.
Lately, she had been arrested three times in a month for the violation of such law. Michele had also encountered the problem of alcohol along with her problem of smoking pot and marijuana, but she has not been arrested for excess drinking and violation of Health and Safety laws related to alcohol. She had not been arrested for any other related crimes, as she normally filched her mother's purse for money whenever needed.
a) Casual drinks offered…...
mlaReferences
Samaha, J. (2007). Criminal Procedure, Seventh Edition, Cengage Learning, USA.
Psychological Element in Drug Use and Dependence
Placebo, the Latin term for "I will please," refers to the psychological positive response that a patient exhibits to a non-specific treatment. It is a purely psychological element, which arises out of the patient's trust in the physician, or the belief in the positive medicinal effects of the drug. Researcher Henry eecher's famous study in 1955 showed that more than 30% of patients respond positively to a placebo. Since then, numerous studies that were focused on the effects of placebo have reported mixed results. The brain imaging study conducted by Leuchter, in 2002, revealed distinct patterns of cerebral blood flow as a response to placebo among depressed subjects. Similarly Evans (2004) reported that placebo effect was quite marked in medical conditions that involved acute phase response. (inflammtion, acute sensitivity, etc.). [Wikipedia] Since placebo trials report significant positive response (at least in one third of…...
mlaBibliography
1) Wikipedia, " Placebo effect," Accessed on 14th Oct 2005, http://en.wikipedia.org/wiki/Placebo_effect
2) University of Colorado, "Psychoactive Drugs and Addiction,"
Accessed on 14th Oct 2005, psych.colorado.edu/~campeaus/2012/StudyguideExam4.PDF
3) University of Waterloo, "Biological and Psychological Models of Drug Use," Accessed on 14th Oct 2005,
Relevant Chapters
Textbook chapters most relevant to this particular component on the relevancy of cost utility and cost effectiveness as it relates to non-pharmacological or supplement treatment effectiveness in comparison to Prozac, will highlight in a balanced manner, the cost benefit of both interventions as evidenced by empirical study. Moreover, the side effects of flouxetine such as nausea, anxiety, insomnia, drowsiness, headaches, and loss of appetite should be taken into consideration when discussing the cost benefit to the client. In addition, any balanced discussion on the subject should include discourse with regard to the propensity for antidepressants to cause increased risk of suicidal ideations as compared to intervention via therapy such as rational emotive or cognitive behavioral therapy (Prigatano & Plinskin, 2003).
Summary
Flouxetine, or Prozac continues to be one of the most prescribed antidepressants for those clinically diagnosed with depression. Since its introduction some 20 years ago, Prozac has been prescribed to…...
mlaBibliography
American Psychiatric Association. (2000). APA practice guidelines for major depressive disorder (2nd ed.). Washington, DC: Author.
Antonuccio, D., Danton, W., & DeNelsky, G. (1995). Psychotherapy vs. medication for Depression: Challenging the conventional wisdom with data. Professional Psychology: Research and Practice, 6, 574-585.
Barrett, B., Byford, S., & Knapp, M. (2005). Evidence of cost-effective treatments for depression: The McSad utility measure for depression health states. Journal of Affective disordersI, 84, 1-13.
Chambless, D., & Hollon, S. (1988). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7-18.
dosage levels of Cholestease on Serum Cholesterol levels and the side effects associated with them in human beings.
Cholesterol has been a major media issue in recent years, especially the negative effects on the heart and its role in the development of heart disease. There have been many studies that indicate a connection between serum cholesterol heart disease and depression (1-3). Developing new methods to lower serum cholesterol has become a major industry in recent years. Currently the leaders in the industry are American Pharmaceutical giants, Pfizer, Merck, and Warner-Lambert (1), who have developed medications that lower cholesterol.
The Endicon corporation recognizes the potential market in developing a drug that will significantly lower serum cholesterol without the side effects associated with long-term use of the drugs currently on the market. In addition, we recognize the potential of developing a ritish Product, primarily marketed in Great ritain. Endicon has been conducting research…...
mlaBibliography
Clarke, R. et al. (1997) Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. Brit. Med. J 314 p.112-117.
Howell, W. et al. (1997) Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am. J. Clin. Nutr. 65 p.1747-1764.
Hudson, M. (2003) How Cholesterol Affects the Body. BurnBraeFarms.com. (Online at ( Accessed June 4, 2003.http://www.burnbraefarms.com/nutrition/cholesterolnews.pdf )
Kronmal, R. et al. (1993)Total Serum Cholesterol Levels and Mortality Risk as a function of Age, A report based on the Framingham Data. Arch. Intern.Med. 153 p. 1065-1073.
Initial product formulation utilizes knowledge acquired from pre-formulation outcomes to derive proper dose, dosage form, and type of administration for the proposed marketed use. A pilot batch of Clinical Trial Materials (CTM) may be produced after the new drug has completed these initial tests.
Upon completion of preclinical testing, the drug sponsor files an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA), after they have obtained prerequisite approval from the Institutional eview Board (IB). The purpose of the investigation is to assure that the new drug is safe and meets stated objectives for human consumption. Among other things, all formulations must meet FDA Current Good Manufacturing Practice guidelines before human testing can begin. Ordinarily, the FDA has 30 days to respond to the application. After the drug receives this initial approval clinical trials may begin within 30 days.
Clinical trials proceed in four phases, with each…...
mlaReferences
Friedhoff, Lawrence, Lawrence T., and M.d. New Drugs: An Insider's Guide to the FDA'New Drug Approval Process for Scientists, Investors and Patients. New York: PSPG Publishing, 2009. Print.
"How Drugs are Developed and Approved." U.S. Food and Drug Administration, Last updated 04/23/2010: Web. 17 Jan 2011. .
Janodia, MD. "Drug Development Process: A Review." Pharmaceutical News 12/25/2007: Web. 17 Jan 2011. .
Mathieu, Mark, and Christopher-Paul Milne. New Drug Development: A Regulatory Overview. 8th. MA: Barnett Educational Services Chi, 2008. Print.
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now